Key result
Carboxymethyl starch sulfate demonstrates optimal anticoagulant activity across standard clotting assays.
Why the study?
A renewable and compatible anticoagulant as a potential heparin alternative was needed and carboxymethyl starch sulfate was developed and characterized for this purpose.
Carboxymethyl starch sulfate demonstrates concentration- and degree of substitution-dependent anticoagulant activity in vitro, suggesting potential as a renewable heparin alternative.
Answers are grounded in this paper and cite their sources.
Should not yet guide clinical anticoagulation; leaves open starch sulfate optimization for therapeutic testing.
To develop a renewable and compatible anticoagulant as potential heparin alternative, carboxymethyl starch sulfate (CMSS) was prepared by the reaction of carboxymethyl starch (CMS) and sulfating reagent [N(SO3Na)3]. The chemical structures of CMS and CMSS were characterized by Fourier transform infrared spectroscopy and 13C nuclear magnetic resonance. The influences of reaction parameters, including the pH of sulfating reagent, the molar ratio of sulfating reagent to CMS, reaction time, and temperature on the degree of substitution of sulfate groups (DS) of CMSS were studied. Meantime, the DS of each CMSS was determined by barium sulfate–glutin nephelometery method. Moreover, the anticoagulant activity of CMSS was investigated by the coagulation assays of activated partial thromboplastin time, thrombin time, and prothrombin time. The results revealed that the anticoagulant activity of CMSS was closely related to the DS value and concentration. The anticoagulant activity was promoted with the increasing of the DS and concentration. The molecular weight (Mw) in measured range had little impact on anticoagulant activity in contract to the DS and concentration. In this article, the CMSS with the DS of 1.91, concentration of 75 μg/mL and the Mw of 2.61 × 104 had the best blood anticoagulant activities.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2012) studied this question. Carboxymethyl starch sulfate (CMSS) was evaluated on Anticoagulant activity (activated partial thromboplastin time, thrombin time, and prothrombin time). Carboxymethyl starch sulfate with a degree of substitution of 1.91, concentration of /mL, and molecular weight of 2.61 × 10^4 demonstrated the best blood anticoagulant activities.
Synapse has enriched 10 related papers. Consider them for comparative context: